Nomura Holdings Reports Record Annual Net Income, Raises 2030 Targets, and Details Strategic Growth
NMR sits 50% above its 52-week low of $6.02 on light trading volume (0.2× avg).
Summary
Nomura Holdings reported record annual net income and raised its 2030 financial targets, driven by strong performance across divisions and strategic acquisitions, alongside continued shareholder return initiatives.
Key Events · Earnings and Guidance · NMR
-
Record Annual Financial Performance
Nomura Holdings reported a record net income attributable to shareholders of ¥362.1 billion for the fiscal year ended March 31, 2026, a 6.3% increase year-over-year. Return on Equity (ROE) reached 10.1%, surpassing the previous 8-10%+ target.
-
Raised 2030 Financial Targets
The company updated its 2030 management vision, setting new quantitative targets of 10-12%+ ROE and income before income taxes exceeding ¥750 billion, reflecting increased confidence in future growth.
-
Strategic Asset Management Acquisition
Nomura completed the acquisition of Macquarie's U.S. and European public asset management business for ¥288.8 billion in December 2025, significantly increasing assets under management to a record ¥136.9 trillion.
-
Continued Shareholder Returns
The company repurchased ¥101.5 billion worth of shares in the fiscal year and announced a new share buyback program of up to ¥60 billion. A total annual dividend of ¥51 per share was declared, maintaining a payout ratio target of at least 50%.
Analysis · NMR · Finance
Nomura Holdings delivered strong annual financial results, achieving record net income and exceeding its ROE target, leading to an upward revision of its 2030 financial goals. The successful integration of the Macquarie asset management business and the establishment of a new Banking Division underscore the company's strategic efforts to diversify revenue streams and expand into growth areas. Continued share buyback programs and a consistent dividend policy reinforce a commitment to shareholder returns, signaling management's confidence in future performance and capital allocation strategy.
At the time of this filing, NMR was trading at $9.03 on NYSE in the Finance sector, with a market capitalization of approximately $25.1B. The 52-week trading range was $6.02 to $9.58. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.